Oxidative Stress and Emergence of Psychosis.
oxidative stress
schizophrenia
ultra-high risk
Journal
Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981
Informations de publication
Date de publication:
21 Sep 2022
21 Sep 2022
Historique:
received:
16
08
2022
revised:
16
09
2022
accepted:
16
09
2022
entrez:
27
10
2022
pubmed:
28
10
2022
medline:
28
10
2022
Statut:
epublish
Résumé
Treatment and prevention strategies for schizophrenia require knowledge about the mechanisms involved in the psychotic transition. Increasing evidence suggests a redox imbalance in schizophrenia patients. This narrative review presents an overview of the scientific literature regarding blood oxidative stress markers' evolution in the early stages of psychosis and chronic patients. Studies investigating peripheral levels of oxidative stress in schizophrenia patients, first episode of psychosis or UHR individuals were considered. A total of 76 peer-reviewed articles published from 1991 to 2022 on PubMed and EMBASE were included. Schizophrenia patients present with increased levels of oxidative damage to lipids in the blood, and decreased levels of non-enzymatic antioxidants. Genetic studies provide evidence for altered antioxidant functions in patients. Antioxidant blood levels are decreased before psychosis onset and blood levels of oxidative stress correlate with symptoms severity in patients. Finally, adjunct treatment of antipsychotics with the antioxidant N-acetyl cysteine appears to be effective in schizophrenia patients. Further studies are required to assess its efficacy as a prevention strategy. Redox imbalance might contribute to the pathophysiology of emerging psychosis and could serve as a therapeutic target for preventive or adjunctive therapies, as well as biomarkers of disease progression.
Identifiants
pubmed: 36290593
pii: antiox11101870
doi: 10.3390/antiox11101870
pmc: PMC9598314
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Nat Rev Neurosci. 2007 Jan;8(1):45-56
pubmed: 17180162
Prostaglandins Leukot Essent Fatty Acids. 2018 Sep;136:103-110
pubmed: 29111383
Psychiatry Res. 2011 May 30;187(3):454-6
pubmed: 21093063
Proc Natl Acad Sci U S A. 2010 Oct 12;107(41):17785-90
pubmed: 20880836
Clin Chem Lab Med. 2000 Dec;38(12):1277-81
pubmed: 11205693
Proc Natl Acad Sci U S A. 2018 Dec 4;115(49):12495-12500
pubmed: 30455310
Schizophr Res. 1996 Mar;19(1):19-26
pubmed: 9147492
Biol Psychiatry. 1991 Aug 15;30(4):409-12
pubmed: 1912133
Eur J Neurosci. 2000 Oct;12(10):3721-8
pubmed: 11029642
Rev Psiquiatr Salud Ment (Engl Ed). 2018 Jul - Sep;11(3):130-140
pubmed: 29691142
Antioxidants (Basel). 2021 Jan 08;10(1):
pubmed: 33430154
Curr Treat Options Psychiatry. 2016;3:133-150
pubmed: 27376016
Eur Arch Psychiatry Clin Neurosci. 2018 Mar;268(2):129-143
pubmed: 27913877
Schizophr Res. 2013 Oct;150(1):163-8
pubmed: 23932664
Biochem Soc Trans. 1997 Aug;25(3):418S
pubmed: 9388648
Prog Neuropsychopharmacol Biol Psychiatry. 2006 May;30(3):512-5
pubmed: 16426720
Arch Gen Psychiatry. 1987 Jul;44(7):660-9
pubmed: 3606332
Prog Neuropsychopharmacol Biol Psychiatry. 2019 Apr 20;91:94-102
pubmed: 30125624
Curr Opin Neurobiol. 2009 Apr;19(2):220-30
pubmed: 19481443
Schizophr Res. 1998 Jun 22;32(1):1-8
pubmed: 9690328
J Psychiatr Res. 1998 Nov-Dec;32(6):385-91
pubmed: 9844955
Trials. 2019 Nov 28;20(1):658
pubmed: 31779696
Clin Chem Lab Med. 2016 Mar;54(3):447-52
pubmed: 26351924
Arch Gen Psychiatry. 2008 Jan;65(1):28-37
pubmed: 18180426
Noro Psikiyatr Ars. 2021 May 17;58(3):184-188
pubmed: 34526839
J Mol Neurosci. 2022 Feb;72(2):217-225
pubmed: 34410570
Physiol Rev. 2001 Apr;81(2):871-927
pubmed: 11274346
Prostaglandins Leukot Essent Fatty Acids. 2015 Oct;101:15-21
pubmed: 26260538
J Neurosci. 1998 Aug 15;18(16):6241-53
pubmed: 9698317
Hum Psychopharmacol. 2013 Jan;28(1):1-6
pubmed: 23124725
Transl Psychiatry. 2017 Aug 22;7(8):e1215
pubmed: 28892069
Antioxidants (Basel). 2021 Oct 27;10(11):
pubmed: 34829575
Mol Psychiatry. 2004 Jul;9(7):684-97, 643
pubmed: 15098003
Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16621-6
pubmed: 17921251
Schizophr Res. 2008 Oct;105(1-3):10-7
pubmed: 18765167
Schizophr Bull. 2014 Nov;40(6):1452-61
pubmed: 24550526
Int J Neuropsychopharmacol. 2021 Sep 21;24(9):710-720
pubmed: 34036323
Curr Mol Med. 2015;15(2):146-67
pubmed: 25732149
J Psychiatr Res. 2015 Sep;68:210-6
pubmed: 26228421
Psychiatry Res. 2003 Dec 1;121(2):109-22
pubmed: 14656446
Schizophr Bull. 2015 Mar;41(2):419-28
pubmed: 25103207
BMC Psychiatry. 2011 Aug 02;11:124
pubmed: 21810251
Mol Psychiatry. 2001 Jan;6(1):66-73
pubmed: 11244487
Psychoneuroendocrinology. 2020 Jan;111:104473
pubmed: 31655452
Prog Neuropsychopharmacol Biol Psychiatry. 2007 Aug 15;31(6):1164-9
pubmed: 17459548
J Mol Neurosci. 2018 Nov;66(3):428-436
pubmed: 30298298
Psychiatry Clin Neurosci. 2006 Aug;60(4):458-64
pubmed: 16884448
Ann Pharmacother. 2001 Dec;35(12):1517-22
pubmed: 11793611
Psychiatry Clin Neurosci. 2019 May;73(5):204-215
pubmed: 30666759
Int J Dev Neurosci. 2011 May;29(3):311-24
pubmed: 20833242
Am J Psychiatry. 1991 Nov;148(11):1474-86
pubmed: 1681750
BMC Psychiatry. 2012 Nov 16;12:200
pubmed: 23158023
Proc Natl Acad Sci U S A. 2013 Jul 23;110(30):12462-7
pubmed: 23840059
JAMA Psychiatry. 2019 Mar 1;76(3):314-323
pubmed: 30624573
Cell Metab. 2011 Apr 6;13(4):361-366
pubmed: 21459321
Prog Neuropsychopharmacol Biol Psychiatry. 2012 Jan 10;36(1):34-8
pubmed: 21896300
Schizophr Bull Open. 2021 Mar 08;2(1):sgab006
pubmed: 33969302
Schizophr Res. 2002 May 1;55(1-2):1-10
pubmed: 11955958
J Psychopharmacol. 2019 Oct;33(10):1199-1214
pubmed: 31039654
J Zhejiang Univ Sci B. 2006 Dec;7(12):981-6
pubmed: 17111467
Parkinsons Dis. 2018 Sep 2;2018:9163040
pubmed: 30245802
Neuropsychobiology. 2009;60(2):87-93
pubmed: 19776652
Sci China Life Sci. 2010 Jan;53(1):112-124
pubmed: 20596963
Schizophr Res. 2017 May;183:64-69
pubmed: 27889384
CNS Drugs. 2016 Jan;30(1):27-39
pubmed: 26801655
Oxid Med Cell Longev. 2016;2016:9616593
pubmed: 27528889
Psychiatry Res. 2012 Dec 30;200(2-3):218-22
pubmed: 22884309
Am J Psychiatry. 1997 Sep;154(9):1248-54
pubmed: 9286184
Schizophr Res. 2006 Jan 31;81(2-3):291-300
pubmed: 16309894
Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):1064-7
pubmed: 21392552
Trends Psychiatry Psychother. 2021 Oct-Dec;43(4):278-285
pubmed: 34982515
Psychopharmacology (Berl). 2005 Nov;182(4):494-8
pubmed: 16133138
J Biol Chem. 2001 Dec 7;276(49):46379-85
pubmed: 11590144
Cogn Neurodyn. 2019 Aug;13(4):357-365
pubmed: 31354881
Aust N Z J Psychiatry. 2020 May;54(5):453-466
pubmed: 31826654
Psychiatry Res. 2020 Nov;293:113467
pubmed: 33198042
J Neurochem. 2006 Jun;97(6):1634-58
pubmed: 16805774
Psychosom Med. 2021 Jun 1;83(5):485-491
pubmed: 34080586
Neuropsychobiology. 2016;73(2):92-7
pubmed: 27003298
Schizophr Res. 2012 Aug;139(1-3):66-72
pubmed: 22555016
Biochem Biophys Res Commun. 2011 Jun 17;409(4):596-602
pubmed: 21539809
Mol Psychiatry. 2010 Oct;15(10):1023-33
pubmed: 19528963
Schizophr Bull. 2018 Oct 17;44(6):1195-1203
pubmed: 29762765
Nat Rev Drug Discov. 2016 Jul;15(7):485-515
pubmed: 26939910
Schizophr Bull. 2016 Sep;42(5):1185-96
pubmed: 27069063
Int J Clin Pract. 2021 Nov;75(11):e14711
pubmed: 34370389
Schizophr Res. 1998 Apr 10;30(3):193-208
pubmed: 9589514
Psychiatry Clin Neurosci. 2018 May;72(5):329-336
pubmed: 29280533
Curr Neuropharmacol. 2009 Mar;7(1):65-74
pubmed: 19721819
Int J Mol Sci. 2015 Aug 19;16(8):19602-11
pubmed: 26295386
Zh Nevrol Psikhiatr Im S S Korsakova. 2020;120(9):66-71
pubmed: 33081449
Antioxidants (Basel). 2018 Nov 06;7(11):
pubmed: 30404130
Indian J Psychiatry. 2008 Jan;50(1):16-20
pubmed: 19771301
Acta Neuropsychiatr. 2019 Dec;31(6):343-347
pubmed: 31364526
Psychoneuroendocrinology. 2015 Jan;51:201-8
pubmed: 25462893
Schizophr Res. 2014 Jun;156(1):23-9
pubmed: 24768133
Mol Psychiatry. 2020 Apr;25(4):873-882
pubmed: 29934548
Front Psychiatry. 2021 Nov 15;12:728986
pubmed: 34867519
BMC Psychiatry. 2011 Feb 14;11:26
pubmed: 21320302
Am J Hum Genet. 2006 Sep;79(3):586-92
pubmed: 16909399
Psychiatry Res. 2021 Apr;298:113832
pubmed: 33652247
Transl Psychiatry. 2017 Mar 21;7(3):e1064
pubmed: 28323286
Neuropsychobiology. 2004;49(4):205-9
pubmed: 15154399
Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):155-9
pubmed: 17804133
Mol Psychiatry. 2021 Jul;26(7):3502-3511
pubmed: 33077854
Prog Neuropsychopharmacol Biol Psychiatry. 2002 Jun;26(5):995-1005
pubmed: 12369276
Schizophr Res. 2016 Sep;176(1):41-51
pubmed: 25000913
Biol Psychiatry. 1998 May 1;43(9):674-9
pubmed: 9583001
BMC Psychiatry. 2014 Sep 24;14:268
pubmed: 25248376
Nat Rev Neurosci. 2005 Apr;6(4):312-24
pubmed: 15803162
Neurotherapeutics. 2021 Apr;18(2):1316-1324
pubmed: 33791970
Schizophr Res. 2002 Nov 1;58(1):1-10
pubmed: 12363384
Indian J Exp Biol. 2002 Nov;40(11):1233-9
pubmed: 13677624
Neurochem Int. 2001 Apr;38(5):425-35
pubmed: 11222923
Trends Neurosci. 2012 Jan;35(1):57-67
pubmed: 22154068
Biol Psychiatry. 1990 Dec 1;28(11):959-66
pubmed: 2275953
Cardiovasc Psychiatry Neurol. 2014;2014:637016
pubmed: 25276418
Clin Neurophysiol. 2013 Nov;124(11):2209-15
pubmed: 23823132
Asian J Psychiatr. 2022 Jan;67:102932
pubmed: 34839098
Schizophr Res. 2012 May;137(1-3):66-72
pubmed: 22445462
Cell Biochem Funct. 2002 Jun;20(2):171-5
pubmed: 11979513
Psychiatry Res. 2015 Aug 30;228(3):688-94
pubmed: 26117246
Biol Psychiatry. 2013 Sep 15;74(6):400-9
pubmed: 23683390
Neurosci Biobehav Rev. 2011 Apr;35(5):1110-24
pubmed: 21115039
CNS Spectr. 2019 Jun;24(3):333-337
pubmed: 29248027
Psychiatry Clin Neurosci. 2015 Nov;69(11):699-707
pubmed: 26172069